Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 3,4 50 5?
Displaying drugs 6401 - 6425 of 10254 in total
Experimental
Matched Name: … 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE …
Matched Iupac: … 2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzamide …
Experimental
Matched Name: … 3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN …
Matched Iupac: … (2R)-2-tert-butyl-N'-(pentan-3-yl)butanediamide …
Experimental
Matched Name: … 3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE …
Matched Iupac: … 3-[(1S)-1-(4-bromophenyl)-2-methylpropyl]-4-hydroxy-2H-chromen-2-one …
Experimental
Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.
Investigational
Matched Iupac: … N-{1-[(3R)-3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl]piperidin-4-yl}-N-ethyl-2-(4-methanesulfonylphenyl …
AZD5423 has been used in trials studying the basic science and treatment of Asthma, Bioavailability and AUC, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Matched Iupac: … 2,2,2-trifluoro-N-[(1R,2S)-1-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-(3-methoxyphenyl)propan-2-yl …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).
Investigational
MEDI-547 is an anti-EphA1 monoclonal antibody conjugated to mcMMAF
Investigational
Experimental
Matched Name: … 3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID …
Matched Iupac: … 3-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl}carbamoyl)thiophene-2-carboxylic acid …
Experimental
Matched Name: … 2-Thiomethyl-3-Phenylpropanoic Acid …
Matched Iupac: … (2S)-2-benzyl-3-sulfanylpropanoic acid …
Experimental
Matched Name: … (6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO …
Matched Iupac: … (2R,3S,9R)-5-acetyl-6-hydroxy-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.0^{2,9}.0^{3,7}.0^{15,18}]octadeca …
Experimental
Matched Name: … 5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one …
Matched Iupac: … 5,8-dimethoxy-1,4-dimethyl-1,2-dihydroquinolin-2-one …
Experimental
Matched Iupac: … (2S)-2-amino-4-(methylcarbamoyl)butanoic acid …
Experimental
Matched Name: … N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE …
Matched Iupac: … 9,10,11,12-tetrabromo-5-methyl-2,5,7-triazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),6,8,10-tetraene …
Odanacatib is an inhibiter of cathepsin K which was originally developed be Merck & Co as a new treatment for osteoporosis . The drug made it to phase III trials before abandoned due to increased stroke.
Investigational
Matched Iupac: … (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4'-methanesulfonyl-[1,1'-biphenyl …
Experimental
Matched Name: … S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate …
Matched Iupac: … N-(2-chloro-4-sulfamoylphenyl)-2-(6-methyl-1,2,3,4-tetrahydroquinoline-1-carbonylsulfanyl)acetamide …
ANEB-001 is under investigation in clinical trial NCT05282797 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test).
Investigational
Matched Synonyms: … 1-AZETIDINECARBOXAMIDE, 3-((R)-(4-CHLOROPHENYL)(2-(TRIFLUOROMETHYL)PHENYL)METHOXY)-N-(1,1-DIMETHYLETHYL ... 3-((R)-(4-CHLOROPHENYL)(2-(TRIFLUOROMETHYL)PHENYL)METHOXY)-N-(1,1-DIMETHYLETHYL)-1-AZETIDINECARBOXAMIDE …
Experimental
Matched Name: … (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine …
Matched Iupac: … (3R,4R)-4-(pyrrolidine-1-carbonyl)-1-(quinoxaline-2-carbonyl)pyrrolidin-3-amine …
Talampanel is a substance that is being studied in the treatment of brain tumors and other brain disorders, such as epilepsy and Parkinson disease. It is a type of AMPA receptor antagonist.
Investigational
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Experimental
Matched Synonyms: … (+)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol …
Matched Iupac: … (2R)-1-(naphthalen-1-yloxy)-3-[(propan-2-yl)amino]propan-2-ol …
Experimental
Matched Name: … 2-Hydroxymethyl-Pyrrolidine-3,4-Diol …
Matched Iupac: … (2S,3S,4S)-2-(hydroxymethyl)pyrrolidine-3,4-diol …
Experimental
Matched Name: … 2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID …
Matched Iupac: … 2-(4-hydroxy-3-nitrophenyl)acetic acid …
Experimental
Matched Name: … 1,3-Bis((1-methylethyl)amino)propan-2-ol …
Matched Iupac: … {2-hydroxy-3-[(propan-2-yl)amino]propyl}(propan-2-yl)amine …
Dehydroascorbic acid is made from the oxidation of ascorbic acid. This reaction is reversible, but dehydroascorbic acid can instead undergo irreversible hydrolysis to 2,3-diketogulonic acid. Dehydroascorbic acid as well as ascorbic acid are both termed Vitamin C, but the latter is the main form found in humans. In the body,...
Experimental
Matched Iupac: … (5R)-5-[(1S)-1,2-dihydroxyethyl]oxolane-2,3,4-trione …
Displaying drugs 6401 - 6425 of 10254 in total